Most Republicans support Medicare for all

Amy Baxter | | Health Exec | Policy & Regulations

While many GOP leaders have demonized a Medicare for all policy popularized by Sen. Bernie Sanders (I-VT), many Republicans are actually supportive of such a proposal, according to a recent poll by HillTV and the HarrisX polling company.

More than half of Republicans polled (52 percent) said they supported a single-payer healthcare system known as Medicare for all, while 48 percent were opposed.

The poll comes as more Democrats are supporting the idea, which has been estimated to cost $32.6 trillion over a decade.

President Trump has been among the most vocal opponents to the idea, penning an op-ed that slammed the proposal and stated people would lose Medicare altogether.

See the full story below:

Majority of Republicans supports 'Medicare for all,' poll finds

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.